13 April, 2006, TAIPEI, Taiwan -- Taipei-based biomedical technology
company Formosa Biomedical Technology Corporation announced its readiness to market
its revolutionary new arterial hardness home healthcare diagnostic device to European
The company's Automatic Digital Blood Pressure
Monitor with Arterial Hardness Value Measurement is a three-in-one electronic
device utilizing medical technology previously available only to doctors in a
hospital setting. Using patented sensor technology, the device determines the
hardness of a person's arteries while simultaneously measuring blood pressure
and heart rate.
hardness is a symptom of arteriosclerosis, a condition where the body's arteries
thicken, harden and become slowly blocked over time due to life style, dietary
and genetic factors. Advanced arteriosclerosis can cause a number of serious health
problems, including cerebral hemorrhage and stroke, angina and heart attacks,
kidney disease and circulatory system breakdown in the limb extremities.
device utilizes technology first invented in Japan and developed and perfected
in the Formosa Biomedical research facilities in Taiwan, into a novel, easy-to-use
"We have developed a product that
lets you take a closer look at your cardiovascular system. By determining your
arterial hardness level, you can uncover potential health problems that otherwise
wouldn't be picked up outside of a medical examination in a hospital," said
Taylor Chang, Deputy Manager of Formosa Biomedical's sales and marketing department.
"We believe that regular testing of arterial hardness is a simple and effective
means of monitoring and safeguarding your health. Our product allows you to do
this at home, at your convenience," he said.
Chan, Executive Vice President of Formosa Biomedical and a Professor at Chang
Gung University Medical School, stated that most people underestimate the risk
of undetected cardiovascular disease.
"Even when coronary
blood vessels are narrowed by as much as 80 percent, symptoms are not usually
apparent to the affected person. However, roughly 60 percent of affected people
die from their first heart attack," stated Chan.
more troubling, said Chan, is that the death rate from heart attack victims with
no history of symptoms is twice as high as that of the general population of heart
attack victims, showing that identification and awareness of cardiovascular disease
symptoms is the key to surviving heart attacks.
introduced the product at November, 2005's Medica exhibition in Germany--the world's
largest exhibition for the medical device equipment industry--to strong interest.
Since then, the company has been to looking to build up a network of qualified
distributors in Europe.
"We are interested in working
with distributors who understand the importance of vascular system monitoring
and are willing to assist in spreading the good news about this revolutionary
product," said Chang.
The Automatic Digital Blood
Pressure Monitor with Arterial Hardness Value Measurement has received FDA
and CE approval for its class of devices. Formosa Biomedical is interested in
receiving applications from all interested parties looking to become agents for
the product in European countries. Please enquire with Taylor Chang at the contact